Clinical implications of enzyme induction.
D000818:Animals; D001463:Barbiturates / Q000494:pharmacology; D001646:Bile / Q000378:metabolism; D001663:Bilirubin / Q000378:metabolism; D004074:Digitoxin / Q000378:metabolism; D004790:Enzyme Induction / Q000187:drug effects*; D014453:Glucuronosyltransferase / Q000096:biosynthesis; D006801:Humans; D006854:Hydrocortisone / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology; D006933:Hyperbilirubinemia, Hereditary / Q000201:enzymology; D007700:Kinetics; D008099:Liver / Q000378:metabolism; D008862:Microsomes, Liver / Q000187:drug effects / Q000378:metabolism; D009928:Organ Specificity; D004364:Pharmaceutical Preparations / Q000378:metabolism; D010600:Pharmacology; D010634:Phenobarbital / Q000494:pharmacology; D013448:Sulfobromophthalein / Q000378:metabolism; D013997:Time Factors; D014859:Warfarin / Q000097:blood / Q000627:therapeutic use; D005723:gamma-Glutamyltransferase / Q000097:blood
D001463:Barbiturates; D004364:Pharmaceutical Preparations; D013448:Sulfobromophthalein; D014859:Warfarin; D004074:Digitoxin; D005723:gamma-Glutamyltransferase; D014453:Glucuronosyltransferase; D001663:Bilirubin; D006854:Hydrocortisone; D010634:Phenobarbital